Drug Type Small molecule drug |
Synonyms CPT053, MD-053 |
Target |
Action inhibitors |
Mechanism CDK1 inhibitors(Cyclin-dependent kinase 1 inhibitors), CDK5 inhibitors(Cyclin-dependent kinase 5 inhibitors), GSK-3β inhibitors(Glycogen synthase kinase-3 beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | United States | 01 Jul 2025 |





